Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.24.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Loss from continuing operations $ (421,604) $ (1,319,994) $ (1,814,999) $ (3,861,035)  
Adjustments to reconcile net loss from continuing operations to net cash used in operating activities - continuing operations:          
Depreciation and amortization     163,209 428,655  
Deferred income taxes     0 (20,840)  
Noncash lease expense     68,541 68,540  
Stock-based compensation expense     138,038 262,248  
Allowance for credit losses     4,431 1,895 $ (15,761)
Amortization of commitment funding     (281,250) 0  
Loss on disposal of property, plant and equipment     1,329 0  
Changes in operating assets and liabilities, net of effects of discontinued operations:          
Accounts receivable     149,569 411,971  
Prepaid expenses and other current assets     360,180 350,844  
Accounts payable     130,863 298,067  
Accrued expenses     (3,142) (152,067)  
Lease liability     (79,045) (77,207)  
Deferred revenue     (162,198) (126,294)  
Net cash used in operating activities - continuing operations     (1,324,474) (2,415,223)  
Net cash used in operating activities - discontinued operations     0 (27,956)  
Net cash used in operating activities     (1,324,474) (2,443,179)  
Cash flows from investing activities:          
Payments for technology developed     (201,620) (114,494)  
Purchases of property and equipment     0 (12,456)  
Acquisition of assets of Expo Experts     0 (400,000)  
Additional acquisition of equity interest in RemoteMore USA, Inc.     0 (351,633)  
Net cash used in investing activities     (201,620) (878,583)  
Cash flows from financing activities:          
Proceeds from the sale of common stock     949,990 2,700,000  
Proceeds from noncontrolling interests     82,140  
Net cash provided by (used in) financing activities     1,032,130 2,700,000  
Effect of exchange rate fluctuations on cash and cash equivalents     0 124  
Net decrease in cash and cash equivalents     (493,964) (621,638)  
Cash, cash equivalents, beginning of period     627,641 1,236,771 1,236,771
Cash and cash equivalents, end of period $ 133,677 $ 615,133 133,677 615,133 $ 627,641
Supplemental disclosures of other cash flow information:          
Non-cash stock issuance     0 200,000  
Cash paid for income taxes     $ 0 $ 3,690